{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:43:49Z","timestamp":1793396629804,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.diabres.2022.110013","type":"journal-article","created":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T22:02:52Z","timestamp":1658354572000},"page":"110013","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Prediction of complications of type 2 Diabetes: A Machine learning approach"],"prefix":"10.1016","volume":"190","author":[{"given":"Antonio","family":"Nicolucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Bernardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Vespasiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Petrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ceriello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Di Bartolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Frontoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Vespasiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2022.110013_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2022.110013_b0010","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.2522\/ptj.20080020","article-title":"Epidemiology of diabetes and diabetes-related complications","volume":"88","author":"Deshpande","year":"2008","journal-title":"Phys Ther"},{"key":"10.1016\/j.diabres.2022.110013_b0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-018-4711-2","article-title":"Global trends in diabetes complications: a review of current evidence","volume":"62","author":"Harding","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2022.110013_b0020","first-page":"e62","article-title":"Relationship of diabetes complications severity to healthcare utilization and costs among Medicare Advantage beneficiaries","volume":"21","author":"Hazel-Fernandez","year":"2015","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.diabres.2022.110013_b0025","doi-asserted-by":"crossref","unstructured":"UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853. PMID: 9742976.","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"10.1016\/j.diabres.2022.110013_b0030","doi-asserted-by":"crossref","unstructured":"UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998;317:703\u2013713. PMID: 9732337.","DOI":"10.1136\/bmj.317.7160.703"},{"issue":"9435","key":"10.1016\/j.diabres.2022.110013_b0035","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.diabres.2022.110013_b0040","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes","volume":"348","author":"G\u00e6de","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2022.110013_b0045","doi-asserted-by":"crossref","unstructured":"Look AHEAD Research Group; Gregg E,Jakicic J, Blackburn G, et al. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol 2016;4:913\u2013921. DOI: 10.1016\/S2213-8587(16)30162-0.","DOI":"10.1016\/S2213-8587(16)30162-0"},{"key":"10.1016\/j.diabres.2022.110013_b0050","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1161\/CIRCULATIONAHA.115.017926","article-title":"Relation of smoking with total mortality and cardiovascular events among patients with diabetes mellitus","volume":"132","author":"Pan","year":"2015","journal-title":"Circulation"},{"issue":"10166","key":"10.1016\/j.diabres.2022.110013_b0055","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","article-title":"SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"393","author":"Zelniker","year":"2019","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.diabres.2022.110013_b0060","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S2213-8587(19)30249-9","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"7","author":"Kristensen","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"10.1016\/j.diabres.2022.110013_b0065","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S2213-8587(19)30256-6","article-title":"SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"7","author":"Neuen","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"10.1016\/j.diabres.2022.110013_b0070","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1002\/ehf2.13169","article-title":"Efficacy and safety of SGLT2 inhibitors in heart failure: systematic review and meta-analysis","volume":"7","author":"Butler","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.diabres.2022.110013_b0075","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.diabet.2017.06.003","article-title":"Clinical inertia and its impact on treatment intensification in people with type 2 diabetes mellitus","volume":"43","author":"Reach","year":"2017","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabres.2022.110013_b0080","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/ijcp.12906","article-title":"Under-treatment of type 2 diabetes: Causes and outcomes of clinical inertia","volume":"70","author":"Bailey","year":"2016","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.diabres.2022.110013_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109096","article-title":"Temporal trends in intensification of glucose-lowering therapy for type 2 diabetes in Italy: Data from the AMD Annals initiative and their impact on clinical inertia","volume":"181","author":"Cucinotta","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2022.110013_b0090","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2337\/diacare.24.9.1547","article-title":"Developing a prediction rule from automated clinical databases to identify high-risk patients in a large population with diabetes","volume":"24","author":"Selby","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2022.110013_b0095","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s00125-013-2940-y","article-title":"UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82","volume":"56","author":"Hayes","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2022.110013_b0100","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/dom.12686","article-title":"Risk prediction of major complications in individuals with diabetes: the Atherosclerosis Risk in Communities Study","volume":"18","author":"Parrinello","year":"2016","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"10.1016\/j.diabres.2022.110013_b0105","doi-asserted-by":"crossref","first-page":"852","DOI":"10.2337\/dc19-2057","article-title":"Predicting 10-year risk of end-organ complications of type 2 diabetes with and without metabolic surgery: a machine learning approach","volume":"43","author":"Aminian","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2022.110013_b0110","article-title":"Longitudinal risk prediction of chronic kidney disease in diabetic patients using a temporal-enhanced gradient boosting machine: retrospective cohort study","volume":"8","author":"Song","year":"2020","journal-title":"JMIR Med Inf"},{"issue":"1","key":"10.1016\/j.diabres.2022.110013_b0115","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48263-5","article-title":"Artificial intelligence predicts the progression of diabetic kidney disease using big data machine learning","volume":"9","author":"Makino","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.diabres.2022.110013_b0120","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1177\/0962280218810911","article-title":"Predicting diabetes-related hospitalizations based on electronic health records","volume":"28","author":"Brisimi","year":"2019","journal-title":"Stat Methods Med Res"},{"issue":"2","key":"10.1016\/j.diabres.2022.110013_b0125","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/1932296817706375","article-title":"Machine learning methods to predict diabetes complications","volume":"12","author":"Dagliati","year":"2018","journal-title":"J Diabetes Sci Technol"},{"issue":"1","key":"10.1016\/j.diabres.2022.110013_b0130","doi-asserted-by":"crossref","DOI":"10.1038\/s41746-021-00394-8","article-title":"Predicting adverse outcomes due to diabetes complications with machine learning using administrative health data","volume":"4","author":"Ravaut","year":"2021","journal-title":"NPJ Digit Med"},{"issue":"12","key":"10.1016\/j.diabres.2022.110013_b0135","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.2337\/dc19-0587","article-title":"Machine learning to predict the risk of incident heart failure hospitalization among patients with diabetes: the WATCH-DM risk score","volume":"42","author":"Segar","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2022.110013_b0140","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/cts.12647","article-title":"Prediction of nephropathy in type 2 diabetes: an analysis of the ACCORD trial applying machine learning techniques","volume":"12","author":"Rodriguez-Romero","year":"2019","journal-title":"Clin Transl Sci"},{"issue":"1","key":"10.1016\/j.diabres.2022.110013_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/ci0342472","article-title":"The problem of overfitting. Journal of chemical information and computer sciences","volume":"44","author":"Hawkins","year":"2004","journal-title":"J Chem Inf Comput Sci"},{"key":"10.1016\/j.diabres.2022.110013_b0150","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3233\/IDA-2002-6504","article-title":"The class imbalance problem: A systematic study","volume":"6","author":"Japkowicz","year":"2002","journal-title":"Intelligent data analysis Intelligent Data Analysis"},{"key":"10.1016\/j.diabres.2022.110013_b0155","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1613\/jair.953","article-title":"SMOTE: synthetic minority over-sampling technique","volume":"16","author":"Chawla","year":"2002","journal-title":"Journal of artificial intelligence research JAIR"},{"issue":"4","key":"10.1016\/j.diabres.2022.110013_b0160","first-page":"1","article-title":"Xgboost: extreme gradient boosting","volume":"1","author":"Chen","year":"2015","journal-title":"R package version 04-2"},{"key":"10.1016\/j.diabres.2022.110013_b0165","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1109\/JBHI.2019.2899218","article-title":"Discovering the type 2 diabetes in electronic health records using the sparse balanced support vector machine","volume":"24","author":"Bernardini","year":"2019","journal-title":"IEEE J Biomed Health Inform"},{"issue":"1","key":"10.1016\/j.diabres.2022.110013_b0170","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3390\/diagnostics12010134","article-title":"Review of Machine Learning Applications Using Retinal Fundus Images","volume":"12","author":"Jeong","year":"202212134","journal-title":"Diagnostics (Basel)"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722008270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722008270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:23:36Z","timestamp":1759173816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822722008270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":34,"alternative-id":["S0168822722008270"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2022.110013","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of complications of type 2 Diabetes: A Machine learning approach","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2022.110013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110013"}}